ArticleInternal and emergency medicine2021
Predictors of mortality of COVID-19 in the general population and nursing homes.
Article in Internal and emergency medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04463706 (Clinical Characterization of CoVid19 Infection), which is not on this map. Cited by 35 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Clinical Characterization of CoVid19 Infection: Prognostic Stratification and Complications
Who cites it
35 citing papers in PubMed, 59 citations in OpenAlex.
- Modelling the risk of hospital admission of lab confirmed SARS-CoV-2-infected patients in primary care: a population-based study.Internal and emergency medicine · 2022Trial
- Risk factors for 30-day COVID-19 mortality among people living with dementia in Alberta, Canada: a retrospective cohort study.BMC geriatrics · 2025Article
- Charlson comorbidity index has no incremental value for mortality risk prediction in nursing home residents with COVID-19 disease.BMC geriatrics · 2025Observational
- Development and validation of a risk prediction model for hospital admission in COVID-19 patients presenting to primary care.The European journal of general practice · 2024Article
- Article
- Article
- Restrictions on Hospital Referrals from Long-Term Care Homes in Madrid and COVID-19 Mortality from March to June 2020: A Systematic Review of Studies Conducted in Spain.Epidemiologia (Basel, Switzerland) · 2023Article
- Risk factors for developing symptomatic COVID-19 in older residents of nursing homes: A hypothesis-generating observational study.Journal of frailty, sarcopenia and falls · 2023Article
- Serum lipid mediator profiles in COVID-19 patients and lung disease severity: a pilot study.Scientific reports · 2023Article
- [Long-term care facilities-the COVID-19 pandemic as an urgent call: infection prevention, control measures, and factors influencing the health of residents].Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz · 2023Review
- Multimorbidity and SARS-CoV-2-Related Outcomes: Analysis of a Cohort of Italian Patients.JMIR public health and surveillance · 2023Article
- Cardiovascular Reasons for Access to a Tertiary Oncological Emergency Service: The CARILLON Study.Journal of clinical medicine · 2023Article
- Short-term safety of COVID-19 mRNA vaccines with respect to all-cause mortality in the older population in Norway.Vaccine · 2023Article
- Interferon-λ treatment accelerates SARS-CoV-2 clearance despite age-related delays in the induction of T cell immunity.Nature communications · 2022Article
- Risk factors associated with COVID-19 infection and mortality in nursing homes.Atencion primaria · 2022Article
- Systematic Review and Meta-Analysis of Statin Use and Mortality, Intensive Care Unit Admission and Requirement for Mechanical Ventilation in COVID-19 Patients.Journal of clinical medicine · 2022Review
- Managing the Impact of COVID-19 in Nursing Homes and Long-Term Care Facilities: An Update.Journal of the American Medical Directors Association · 2022Article
- Testing and vaccination to reduce the impact of COVID-19 in nursing homes: an agent-based approach.BMC infectious diseases · 2022Article
- Community predictors of COVID-19 cases and deaths in Massachusetts: Evaluating changes over time using geospatially refined data.Influenza and other respiratory viruses · 2022Article
- COVID-19 in young and middle-aged adults: predictors of poor outcome and clinical differences.Infection · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 5 institutions in 1 country.
Funding
Abstract
The factors that predispose an individual to a higher risk of death from COVID-19 are poorly understood. The goal of the study was to identify factors associated with risk of death among patients with COVID-19. This is a retrospective cohort study of people with laboratory-confirmed SARS-CoV-2 infection from February to May 22, 2020. Data retrieved for this study included patient sociodemographic data, baseline comorbidities, baseline treatments, other background data on care provided in hospital or primary care settings, and vital status. Main outcome was deaths until June 29, 2020. In the multivariable model based on nursing home residents, predictors of mortality were being male, older than 80 years, admitted to a hospital for COVID-19, and having cardiovascular disease, kidney disease or dementia while taking anticoagulants or lipid-lowering drugs at baseline was protective. The AUC was 0.754 for the risk score based on this model and 0.717 in the validation subsample. Predictors of death among people from the general population were being male and/or older than 60 years, having been hospitalized in the month before admission for COVID-19, being admitted to a hospital for COVID-19, having cardiovascular disease, dementia, respiratory disease, liver disease, diabetes with organ damage, or cancer while being on anticoagulants was protective. The AUC was 0.941 for this model's risk score and 0.938 in the validation subsample. Our risk scores could help physicians identify high-risk groups and establish preventive measures and better follow-up for patients at high risk of dying.ClinicalTrials.gov Identifier: NCT04463706.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.